Randomized Study of Triple Therapy vs Sildenafil Dose Optimization in Pulmonary Arterial Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 196 participants.
Also called NCT07713914
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 196 participants
- Registry
-
NCT07713914
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Recruiting
Technical summary
Registry record NCT07713914. Randomized; no masking; primary purpose treatment. Start 2026-07-22 (anticipated); primary completion 2028-07-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomized Study of Triple Therapy vs Sildenafil Dose Optimization in Pulmonary Arterial Hypertension
- Acronym
- ASCEND-PAH
- Condition
- Pulmonary Arterial Hypertension (PAH)
- Intervention (Drug)
- Prostacyclin Pathway Agent
- Intervention (Drug)
- Sildenafil Dose Optimization
- Lead sponsor
- University of Sao Paulo General Hospital
Record details
- Record id
cardio:ct-nct07713914- Content hash
dac95219f4bacf38cc32901c49566facaefdb972e4fd36ae9439acecead50fdf